Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities
Net earnings (loss)	$ 142	$ 193	[1]
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Other charges (gains), net of amounts used	(4)	(4)
Depreciation, amortization and accretion	80	77
Pension and postretirement benefit expense	(5)	3	[1]
Pension and postretirement contributions	(19)	(66)	[1]
Deferred income taxes, net	(8)	(91)	[1]
(Gain) loss on disposition of businesses and assets, net	1	0
Other, net	2	72
Operating cash provided by (used in) discontinued operations	1	0
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	(100)	(47)
Inventories	(55)	(32)
Other assets	(7)	19
Trade payables - third party and affiliates	36	123
Other liabilities	83	(32)	[1]
Net cash provided by (used in) operating activities	147	215
Investing activities
Capital expenditures on property, plant and equipment	(74)	(106)
Acquisitions, net of cash acquired	0	(23)
Proceeds from sale of businesses and assets, net	0	0
Capital expenditures related to Kelsterbach plant relocation	(3)	(21)
Other, net	(10)	(5)
Net cash provided by (used in) investing activities	(87)	(155)
Financing activities
Short-term borrowings (repayments), net	(19)	10
Proceeds from short-term debt	24	24
Repayments of short-term debt	(24)	(24)
Proceeds from long-term debt	50	0
Repayments of long-term debt	(55)	(8)
Purchases of treasury stock, including related fees	0	(20)
Stock option exercises	1	7
Series A common stock dividends	(12)	(10)
Other, net	0	0
Net cash provided by (used in) financing activities	(35)	(21)
Exchange rate effects on cash and cash equivalents	(6)	6
Net increase (decrease) in cash and cash equivalents	19	45
Cash and cash equivalents as of beginning of period	959	682
Cash and cash equivalents as of end of period	$ 978	$ 727

[1] As Adjusted (Note 1)